This study shows that increased circulating levels of TGFβ1 under diabetic conditions are associated with the increased activation of TGFβ1, insulin resistance, and accelerated progression of kidney fibrosis and renal dysfunction. Here, TGFB1 is linked to Abnormal renal physiology.